| Name | Evunzekibart |
|---|
| Description | Evunzekibart (ATOR-1017) is an Fc-γ receptor conditional 4-1BB agonist and IgG4-type antibody. Evunzekibart can be used as monotherapy or in combination with anti-PD1 to exert anticancer activity. |
|---|---|
| Related Catalog | |
| Target |
4-1BB/TNFRSF9 |
| No Any Chemical & Physical Properties |